AU2003275360A1 - Aqueous 2,6-diisopropylphenol pharmaceutical compositions - Google Patents

Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Info

Publication number
AU2003275360A1
AU2003275360A1 AU2003275360A AU2003275360A AU2003275360A1 AU 2003275360 A1 AU2003275360 A1 AU 2003275360A1 AU 2003275360 A AU2003275360 A AU 2003275360A AU 2003275360 A AU2003275360 A AU 2003275360A AU 2003275360 A1 AU2003275360 A1 AU 2003275360A1
Authority
AU
Australia
Prior art keywords
diisopropylphenol
aqueous
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275360A
Other versions
AU2003275360A8 (en
Inventor
Orn Almarsson
Hongming Chen
Zhong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transform Pharmaceuticals Inc
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/629,308 external-priority patent/US7915317B2/en
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of AU2003275360A1 publication Critical patent/AU2003275360A1/en
Publication of AU2003275360A8 publication Critical patent/AU2003275360A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU2003275360A 2002-10-29 2003-10-02 Aqueous 2,6-diisopropylphenol pharmaceutical compositions Abandoned AU2003275360A1 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US42219502P 2002-10-29 2002-10-29
US60/422,195 2002-10-29
US43697902P 2002-12-30 2002-12-30
US60/436,979 2002-12-30
US44349003P 2003-01-29 2003-01-29
US60/443,490 2003-01-29
US46245003P 2003-04-11 2003-04-11
US60/462,450 2003-04-11
US46431403P 2003-04-21 2003-04-21
US60/464,314 2003-04-21
US47040303P 2003-05-14 2003-05-14
US60/470,403 2003-05-14
US48535403P 2003-07-07 2003-07-07
US60/485,354 2003-07-07
US10/629,308 2003-07-29
US10/629,308 US7915317B2 (en) 2002-07-29 2003-07-29 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
PCT/US2003/031086 WO2004039360A1 (en) 2002-10-29 2003-10-02 Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AU2003275360A1 true AU2003275360A1 (en) 2004-05-25
AU2003275360A8 AU2003275360A8 (en) 2004-05-25

Family

ID=32234547

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275360A Abandoned AU2003275360A1 (en) 2002-10-29 2003-10-02 Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Country Status (3)

Country Link
EP (1) EP1556022A4 (en)
AU (1) AU2003275360A1 (en)
WO (1) WO2004039360A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
EP3946316A4 (en) * 2019-04-05 2023-01-11 Sorrento Therapeutics, Inc. Cannabidiol pharmaceutical compositions
CN114601800B (en) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 Sterile sodium methylparaben powder injection and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
IL141095A0 (en) * 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
CA2377614C (en) * 1999-06-21 2008-07-29 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics

Also Published As

Publication number Publication date
EP1556022A1 (en) 2005-07-27
WO2004039360A1 (en) 2004-05-13
WO2004039360B1 (en) 2004-06-17
AU2003275360A8 (en) 2004-05-25
EP1556022A4 (en) 2010-03-10

Similar Documents

Publication Publication Date Title
HK1077515A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AU2003291103A1 (en) Pharmaceutical composition
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2003250372A1 (en) Pharmaceutical composition
AP2004003066A0 (en) Pharmaceutical compositions based on azetidine derivatives.
AU2001273919A1 (en) Pharmaceutical compositions
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2002338201A1 (en) Anthelmintic composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003275360A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
ZA200110500B (en) Pharmaceutical composition.
AUPR529701A0 (en) Pharmaceutical composition
MXPA03007318A (en) Pharmaceutical composition.
ZA200500742B (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2003216904A1 (en) Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
AUPS188302A0 (en) Pharmaceutical composition
AU2002346223A1 (en) Medicinal compositions
ZA200110501B (en) Pharmaceutical composition.
AU2001285737A1 (en) Pharmaceutical compositions
AU2003255737A1 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
AU2002361987A1 (en) Substituted beta-aminoalcohols used as medicaments
ZA200110499B (en) Pharmaceutical composition.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase